Tyme
tyme.ai
Actively hiring
Catering & Food Services
Commerce
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$250M
1 round on record
Latest round
$250M
Series D · Dec 2024 · 21 mo ago
Team
501-1000
employees, estimated range
The money's age
Due for its next round
21 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Dec 17, 2024
Raised a round Series D $250M · led by Nubank · TechCrunch
Apr 1, 2021
New executive TYME Announces Appointment of Dr. Jan M Van Tornout as Acting Chief Medical Officer · businesswire
2017
Founded
Tractionpublic signals, read monthly
Web presence
top 10%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Series D | Dec 2024 | $250M | Nubank lead | TechCrunch |
Registers and programsofficial lists and records that name the company
| Legal entity | Tyme Commerce, Inc. | its site |
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Incentivio is a Boston restaurant technology company founded in 2016. Its platform provides digital ordering, loyalty and guest data tools…
Order Catapult is the brand of Catapult Concepts, a food tech startup that helps commercial kitchens use the food delivery market with…
LANCH is a German food startup behind the restaurant brands Loco Chicken and Happy Slice. It offers franchise partnerships and lets…
Discover and try new restaurants with NeoTaste. 2-for-1 main course, a starter with the main course for free, and other cool deals!
MarginEdge is a Virginia restaurant software company founded in 2015. Its platform digitises invoices and links them to recipes and…
Company Helping QSRs serve faster and smarter We're obsessed with QSR performance. Fingermark provides purpose-built tech – vision AI…
News
African digital bank Tyme raises $250M round led by Nubank at $1.5B valuation
Tyme Group, a South African fintech, has secured $250 million in a Series D round, pushing its valuation to $1.5 billion. The funding was led by Nu Holdings, which owns Latin America's most valuable fintech Nubank, investing $150 million for a 10% stake.
Read more
Report
African digital bank Tyme raises $250M round led by Nubank at $1.5B valuation
Tyme Group raises $250 million in a Series D round, pushing its valuation to $1.5 billion. The funding was led by Brazil's Nubank.
Read more
Report
New Acquisition Helps Tyme Commerce and Raydiant Take Their Partnership to the Next Level
/PRNewswire/ -- Raydiant
Read more
Report
TYME Technologies, Inc. Provides Business Update and Announces Third Fiscal Quarter 2022 Financial and Operating Results
TYME Technologies, Inc. (Nasdaq: TYME) (the Company or TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs), announ...
Read more
Report
TYME Technologies, Inc. Provides Business Update and Announces Second Fiscal Quarter 2022 Financial and Operating Results
TYME Technologies, Inc. (Nasdaq: TYME) (the Company or TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs), announ...
Read more
Report
TYME Technologies, Inc. Provides Business Update and Announces Second Fiscal Quarter 2022 Financial and Operating Results
TYME Technologies, Inc., an emerging biotechnology company developing cancer metabolism-based therapies, announced financial and operating results for its second fiscal quarter ended September 30, 2021. Second Fiscal Quarter 2022 Business and Recent Highl
Read more
Report
Tyme Granted U.S. Patent Claims Covering Use of Tyrosine-Based Drug Delivery Method to Treat Cancer
Tyme Technologies, Inc., an emerging biotechnology company developing cancer metabolism-based therapies, announced that it has received notification that the United States Patent and Trademark Office has granted additional patent claims related to the Com
Read more
Report
TYME Announces Appointment of Dr. Jan M Van Tornout as Acting Chief Medical Officer
Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs), today announced the appointm...
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Mountain View
United States
HQ
500-1000 est. staff
Financials
Total raised
$250M
Latest round
Series D
Funding rounds
1
Funding rounds
| Round | Announced | Amount | Valuation | |
|---|---|---|---|---|
| Series D | 2024 | $250M | $1.5B | Details |